Guidelines on myocardial revascularization
Author:
- The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)T(The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
- 1 September 2010
- journal article
- practice guideline
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 38 (Supplement) , S1-S52
Abstract
Guidelines and Expert Consensus Documents summarize and\ud evaluate all available evidence with the aim of assisting\ud physicians in selecting the best management strategy for an\ud individual patient suffering from a given condition, taking\ud into account the impact on outcome and the risk benefit\ud ratio of diagnostic or therapeutic means. Guidelines are no\ud substitutes for textbooks and their legal implications have\ud been discussed previously. Guidelines and recommendations should help physicians to make decisions in their daily\ud practice. However, the ultimate judgement regarding the\ud care of an individual patient must be made by his/her\ud responsible physician(s).\ud The recommendations for formulating and issuing ESC\ud Guidelines and Expert Consensus Documents can be found\ud on the ESC website (http://www.escardio.org/knowledge/\ud guidelines/rules).\ud Members of this Task Force were selected by the European\ud Society of Cardiology (ESC) and the European Association for\ud Cardio-Thoracic Surgery (EACTS) to represent all physicians\ud involved with the medical and surgical care of patients\ud with coronary artery disease (CAD). A critical evaluation\ud of diagnostic and therapeutic procedures is performed\ud including assessment of the risk benefit ratio. Estimates\ud of expected health outcomes for society are included,\ud where data exist. The level of evidence and the strength\ud of recommendation of particular treatment options are\ud weighed and graded according to predefined scales, as\ud outlined in Tables 1 and 2.\ud The members of the Task Force have provided disclosure\ud statements of all relationships that might be perceived as\ud real or potential sources of conflicts of interest. These\ud disclosure forms are kept on file at European Heart House,\ud headquarters of the ESC. Any changes in conflict of interest\ud that arose during the writing period were notified to the ESC.\ud The Task Force report received its entire financial support\ud from the ESC and EACTS, without any involvement of the\ud pharmaceutical, device, or surgical industry.\ud ESC and EACTS Committees for Practice Guidelines are\ud responsible for the endorsement process of these joint\ud Guidelines. The finalized document has been approved by all\ud the experts involved in the Task Force, and was submitted to\ud outside specialists selected by both societies for review. The\ud document is revised, and finally approved by ESC and EACTS and subsequently published simultaneously in the European\ud Heart Journal and the European Journal of Cardio-Thoracic\ud Surgery.\ud After publication, dissemination of the Guidelines is of\ud paramount importance. Pocket-sized versions and personal\ud digital assistant-downloadable versions are useful at the\ud point of care.\ud Some surveys have shown that the intended users are\ud sometimes unaware of the existence of guidelines, or simply\ud do not translate them into practice. Thus, implementation\ud programmes are needed because it has been shown that\ud the outcome of disease may be favourably influenced by the\ud thorough application of clinical recommendationsKeywords
This publication has 257 references indexed in Scilit:
- Immediate vs Delayed Intervention for Acute Coronary SyndromesJAMA, 2009
- Primary Percutaneous Coronary Intervention Compared With Fibrinolysis for Myocardial Infarction in Diabetes MellitusArchives of internal medicine (1960), 2007
- Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or RepairJAMA, 2005
- Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery DiseaseJAMA, 2005
- Routine vs Selective Invasive Strategies in Patients With Acute Coronary SyndromesJAMA, 2005
- Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom OnsetA Randomized Controlled TrialJAMA, 2005
- Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial InfarctionJAMA, 2005
- Prevention of Contrast-Induced Nephropathy With Sodium BicarbonateJAMA, 2004
- Procedural Volume as a Marker of Quality for CABG SurgeryJAMA, 2004
- Evaluation of Prolonged Antithrombotic Pretreatment ("Cooling-Off" Strategy) Before Intervention in Patients With Unstable Coronary SyndromesJAMA, 2003